Very early researchUnknownNCT04637269What this trial is testingAnti-BCMA CAR-T Cell Therapy for the R/R Multiple MyelomaWho this might be right forMultiple Myeloma Xinqiao Hospital of Chongqing 16
Not applicableStudy completedNCT01306773What this trial is testingConvalescent Plasma Treatment in Severe 2009 H1N1 InfectionWho this might be right forInfluenza A The University of Hong Kong 80
Not applicableActive Not RecruitingNCT06479954What this trial is testingNon Interventional Study to Investigate the Safety and Effectiveness in Patients With Relapsed and Refractory Multiple Myeloma Treated With Elranatamab Under the Actual Use.Who this might be right forRelapsed and Refractory Multiple Myeloma (RRMM) Pfizer 1
Not applicableStudy completedNCT01123889What this trial is testingTreatment of the Rotator Cuff Disease With Platelet Rich Plasma InjectionWho this might be right forSubacromial Impingement SyndromePartial Thickness Rotator Cuff Tear Loma Linda University 12
Large-scale testing (Phase 3)Study completedNCT00987389What this trial is testingPlasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated VasculitisWho this might be right forGranulomatosis With Polyangiitis (Wegener's) (GPA)Microscopic Polyangiitis (MPA) University of Pennsylvania 704
Large-scale testing (Phase 3)Looking for participantsNCT05243797What this trial is testingPhase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell TransplantationWho this might be right forMultiple Myeloma European Myeloma Network B.V. 1,594
Not applicableUnknownNCT04389424What this trial is testingRelationship Between Body Composition, Food Consumption, and Micro and Macronutrients With Gene Expression in Breast CancerWho this might be right forBreast CancerEndocrine TherapyEndocrine Therapy Adverse Reaction+3 more Instituto Jalisciense de Cancerologia 300
Testing effectiveness (Phase 2)Study completedNCT00116961What this trial is testingVelcade, Doxil, and Dexamethasone (VDd) as First Line Therapy for Multiple MyelomaWho this might be right forMultiple Myeloma University of Michigan Rogel Cancer Center 40
Early research (Phase 1)Not Yet RecruitingNCT07407010What this trial is testingBCMA/CD3 Bispecific Antibody as Bridging Therapy Before CAR-T Cell Infusion in RRMMWho this might be right forRelapsed Refractory Multiple Myeloma (RRMM) Institute of Hematology & Blood Diseases Hospital, China 10
Large-scale testing (Phase 3)Study completedNCT00330759What this trial is testingStudy of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma.Who this might be right forBone Metastases Amgen 1,779
Not applicableUnknownNCT01075373What this trial is testingA Neurobiological Study on Heterogeneity of Schizophrenia: Genetic Variations and Neurobiological DifferentiationsWho this might be right forSchizophrenia National Taiwan University Hospital 360
Not applicableEnded earlyNCT05971056What this trial is testingProviding Cancer Care Closer to Home for Patients With Multiple MyelomaWho this might be right forMultiple Myeloma Washington University School of Medicine 3
Testing effectiveness (Phase 2)UnknownNCT03767751What this trial is testingA Feasibility and Safety Study of Dual Specificity CD38 and BCMA CAR-T Cell Immunotherapy for Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Chinese PLA General Hospital 80
Early research (Phase 1)Study completedNCT00058227What this trial is testingAlvocidib, Fludarabine Phosphate, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell LymphomaWho this might be right forB-cell Chronic Lymphocytic LeukemiaContiguous Stage II Grade 1 Follicular LymphomaContiguous Stage II Grade 2 Follicular Lymphoma+40 more National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Looking for participantsNCT06505369What this trial is testingBispecific T-cell Redirectors as Part of First Line Treatment in Transplant Eligible Multiple Myeloma PatientsWho this might be right forMultiple Myeloma North Estonia Medical Centre 50
Not applicableUnknownNCT03504631What this trial is testingGenotyping and Phenotyping of CYP2D6 Breast Cancer Patients on TamoxifenWho this might be right forBreast Cancer Female Trisakti University 117
Testing effectiveness (Phase 2)Study completedNCT01790737What this trial is testingFirst Line Treatment Trial in Multiple Myeloma, Finnish Myeloma Group- Multiple Myeloma 02Who this might be right forMultiple Myeloma Kuopio University Hospital 80
Not applicableWithdrawnNCT02668510What this trial is testingRCT Comparing ESWT With PRP for Plantar Fasciitis in High Demand CohortWho this might be right forFasciitis, Plantar Edna Rath
Testing effectiveness (Phase 2)Study completedNCT00036023What this trial is testingChemotherapy Related Anemia in Patients With Non-Myeloid MalignanciesWho this might be right forLymphomaBreast NeoplasmsLung Neoplasms+2 more Amgen
Testing effectiveness (Phase 2)Looking for participantsNCT06140966What this trial is testingStudy to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Therapy in Transplant-eligible, Ultra High-risk, Newly Diagnosed Multiple MyelomaWho this might be right forMultiple MyelomaPrimary Plasma Cell LeukemiaExtramedullary Multiple Myeloma Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 54